SCHEMBL5137397

SCHEMBL5137397

CCCCn1c(-c2ccccc2)nc(-c2ccccc2)c1CN(Cc1ccc(C(C)C)cc1)CC1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 1/20 0.42
CASR P41180 2/20 0.39
TSHR P16473 6/20 0.35
KDM4E B2RXH2 5/20 0.35
ALDH1A1 P00352 5/20 0.35
HSD17B10 Q99714 5/20 0.35
CYP3A4 P08684 4/20 0.35
HPGD P15428 4/20 0.35
HDAC1 Q13547 1/20 0.35
CRHR1 P34998 2/20 0.34
BCHE P06276 1/20 0.33
ALOX15 P16050 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33
ADORA1 P30542 1/20 0.33
LTB4R2 Q9NPC1 1/20 0.33
PTPN22 Q9Y2R2 1/20 0.32
MAPK1 P28482 1/20 0.32
CNR1 P21554 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5135334 0.93 C5AR1 (0.42) C5AR1CASRTSHRKDM4EALDH1A1
SCHEMBL5135713 0.92 C5AR1 (0.44) C5AR1TSHRKDM4EALDH1A1HSD17B10
SCHEMBL5137864 0.92 C5AR1 (0.44) C5AR1TSHRKDM4EALDH1A1HSD17B10
SCHEMBL5135678 0.91 C5AR1 (0.43) C5AR1TSHRKDM4EALDH1A1HSD17B10
SCHEMBL5134999 0.91 C5AR1 (0.44) C5AR1TSHRKDM4EALDH1A1HSD17B10
SCHEMBL5134910 0.91 C5AR1 (0.44) C5AR1TSHRKDM4EALDH1A1HSD17B10
SCHEMBL5135753 0.90 C5AR1 (0.43) C5AR1TSHRKDM4EALDH1A1HSD17B10
SCHEMBL5137114 0.90 C5AR1 (0.43) C5AR1TSHRKDM4EALDH1A1HSD17B10
SCHEMBL5134718 0.90 C5AR1 (0.43) C5AR1TSHRKDM4EALDH1A1HSD17B10
SCHEMBL4764006 0.89 ABCC1 (0.43) C5AR1TSHRKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490044-A4 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORP (US) 2008-04-16 EP disclosed
EP-1490044-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2004-12-29 EP disclosed
WO-2003084524-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2003-10-16 WO disclosed